Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chern E. Oon"'
Publikováno v:
Journal of Traditional and Complementary Medicine, Vol 13, Iss 1, Pp 39-50 (2023)
Background and aim: Gemcitabine remains the cornerstone of pancreatic cancer treatment, despite exhibiting a modest effect on patient survival due to the development of drug resistance. Nuvastatic™ polymolecular botanical drug Orthosiphon stamineus
Externí odkaz:
https://doaj.org/article/3f920f302f7142f593f3452fd4aa48d1
Autor:
Ashwaq H.S. Yehya, Muhammad Asif, Gurjeet Kaur, Loiy E.A. Hassan, Fouad S.R. Al-Suede, Amin M.S. Abdul Majid, Chern E. Oon
Publikováno v:
Journal of Advanced Research, Vol 15, Iss , Pp 59-68 (2019)
Pancreatic cancer has the highest mortality rate among cancers due to its aggressive biology and lack of effective treatment. Gemcitabine, the first line anticancer drug has reduced efficacy due to acquired resistance. The current study evaluates the
Externí odkaz:
https://doaj.org/article/1fcf5fed5dca4f60ae58766b1b187200
Publikováno v:
Biomedical Journal. 44:694-708
Background Pancreatic cancer is one of the most notorious cancers and is known for its highly invasive characteristics, drug resistance, and metastatic progression. Unfortunately, resistance towards gemcitabine develops in many with advanced pancreat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6defd01a33e38aa82d87c4a0cdc8b5f2
https://doi.org/10.1016/j.bj.2020.05.015
https://doi.org/10.1016/j.bj.2020.05.015
Autor:
Hafiza Sidra Yaseen, Malik Saadullah, Chern E. Oon, Ikram Ullah Khan, Mahrukh, Syed Haroon Khalid, Muhammad Asif, Mohammad Saleem, Hafiz Muhammad Zubair, Ashwaq Hs Yehya, Pegah Moradi Khaniabadi
Publikováno v:
Future Microbiology
COVID-19, caused by the SARS-CoV-2 outbreak, has resulted in a massive global health crisis. Bioactive molecules extracted or synthesized using starting material obtained from marine species, including griffithsin, plitidepsin and fingolimod are in c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a0b5f23504b83daf1a40428cfb7c1bb
http://europepmc.org/articles/PMC8592065
http://europepmc.org/articles/PMC8592065
Autor:
Fouad Saleih R. Al-Suede, Aman Shah Abdul Majid, Sultan A M Saghir, Mohamed B. Khadeer Ahamed, Amin Malik Shah Abdul Majid, Chern E. Oon
Publikováno v:
Journal of Angiotherapy. 5
NuvastaticTM is a polymolecular botanical drug formulation containing a proprietary extract of a selected cultivar of Orthosiphon stamineus (OS) code name, C5OSEW5050ESA OS. The anti-angiogenic activity of C5OSEW5050ESA OS was explored by evaluating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe83a2257ed0a014a4ac18f59939eaf6
https://doi.org/10.25163/angiotherapy.51211411913130321
https://doi.org/10.25163/angiotherapy.51211411913130321
Autor:
Sreenivasan Sasidharan, Soundararajan Vijayarathna, Chern E. Oon, Yeng Chen, Jagat R. Kanwar, Subramanion L. Jothy
Publikováno v:
ResearcherID
For years researchers have exerted every effort to improve the influential roles of microRNA (miRNA) in regulating genes that direct mammalian cell development and function. In spite of numerous advancements, many facets of miRNA generation remain un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3621d053da6f3d072269c5c75355e029
https://doi.org/10.2174/1566523214666140302192953
https://doi.org/10.2174/1566523214666140302192953